Completed
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
NCT00303472
- Conditions
- Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +6 more
- Locations
-
Not specified